APC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
13 reviews
Product Citations
publications
M1slash70_APC_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram) (gated on total cells).
  • M1slash70_APC_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram) (gated on total cells).
See APC spectral data
Cat # Size Price Quantity Avail. Save
101211 25 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101212 100 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse, Human, Cross-Reactivity: Chimpanzee, Baboon, Cynomolgus, Rhesus, Rabbit (Lapine)
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone M1/70 has been validated for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, and immunohistochemistry of acetone-fixed frozen sections5,11-13. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/μg, Azide-Free, 0.2 μm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Prislovsky A, Strom T 2013. Exp Hematol. 41:789. PubMed
  2. Johansson J, et al. 2013. J Neurosci. 33:16016. PubMed
  3. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
  4. Haas R 2013. J Immunol. 190:3100. PubMed
  5. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  6. Takeda K, et al. 2014. Am J Pathol. 184:686. PubMed
  7. Iwata-Yoshikawa N, et al. 2014. J Virol. 88:8597. PubMed
  8. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  9. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  10. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  11. Eddens T, et al. 2015. J Immunol. 195: 185 - 193. PubMed
  12. Kolan S, et al. 2015. PLoS One. 10: 0134113. PubMed
  13. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  14. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  15. Sive J, et al. 2015. Leukemia. . PubMed
  16. Shi Y, et al. 2015. Mol Immunol. 66: 208-215. PubMed
  17. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  18. Xiong X, et al. 2015. Stroke. 46: 2271-2276. PubMed
  19. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  20. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  21. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  22. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  23. Elbaz M, et al. 2015. Mol Oncol. 9: 906-919. PubMed
  24. Nasser MW, et al. 2015. Cancer Res . 75: 974-985. PubMed
  25. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  26. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  27. Gabbita S, et al. 2015. PLoS One. 10: e0137305. PubMed
  28. Choi J, et al. 2015. PLoS One. 10: e0138592. PubMed
  29. Liu Y, et al. 2015. Sci Rep. 5:17215. PubMed
  30. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  31. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  32. Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
  33. Ramos-Sevillano E, et al. 2016. PLoS One. 12: 1005500. PubMed
  34. Cuesta M, et al. 2016. J Immunol. 196: 2466 - 2475. PubMed
  35. Corrales L, et al. 2016. J Immunol. 196: 3191-3198. PubMed
  36. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  37. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  38. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  39. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  40. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  41. Fukasawa K, et al. 2016. Sci Rep. 6:30918. PubMed
  42. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  43. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  44. O’Dea K, et al. 2016. PLoS One. 11:e0167801. PubMed
  45. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  46. Liu Y, et al. 2017. J Neurosci. 37(4):871-881. PubMed
  47. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  48. Sauma D, et al. 2017. Immunol Res. 10.1007/s12026-017-8936-9. PubMed
  49. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  50. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  51. BÖiers C, et al. 2018. Dev Cell. 44:362. PubMed
  52. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  53. Wang F, et al. 2018. Oncogenesis. 7:41. PubMed
  54. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  55. Chattopadhyay A, et al. 2018. Sci Rep. 8:9032. PubMed
  56. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  57. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  58. Uribe-Herranz M, et al. 2018. JCI Insight. 3. PubMed
  59. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  60. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  61. Colliou N, et al. 2018. Gut Microbes. 9:279. PubMed
  62. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  63. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  64. Sanders KA, et al. 2019. Sci Rep. 9:231. PubMed
  65. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  66. Yu Y, et al. 2019. J Clin Invest. 129:546. PubMed
  67. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  68. Perdomo J, et al. 2019. Nat Commun. 10:1322. PubMed
  69. Ayoub M, et al. 2019. Sci Rep. 9:6348. PubMed
  70. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  71. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  72. Steinkühler J, et al. 2018. J Cell Sci. 132. PubMed
  73. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  74. Page N, et al. 2018. Immunity. 48:937. PubMed
  75. Haloul M, et al. 2019. Sci Rep. 9:14050. PubMed
  76. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  77. Tang Y, et al. 2019. Nat Commun. 10:4157. PubMed
  78. Nowak WN, et al. 2019. Mediators Inflamm. 2019:1868170. PubMed
  79. Schroder WA, et al. 2019. Sci Rep. 9:12421. PubMed
  80. Vásquez M, et al. 2019. J Immunol. 203:696. PubMed
  81. Gomes T, et al. 2019. Front Immunol. 10:2088. PubMed
  82. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  83. Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed
  84. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  85. Nakamura K et al. 2018. Cancer cell. 33(4):634-648 . PubMed
  86. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  87. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  88. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  89. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  90. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  91. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  92. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  93. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  94. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  95. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  96. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  97. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  98. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  99. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  100. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  101. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  102. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  103. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  104. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  105. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  106. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  107. Xu X, et al. 2018. Cell. 175:1336. PubMed
  108. Thurlow LR, et al. 2018. Cell Host Microbe. 24:261. PubMed
  109. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  110. Hernández–Santos N, et al. 2018. Cell Host Microbe. 1.313194444. PubMed
  111. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  112. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  113. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  114. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  115. Horn LA, et al. 2017. Oncotarget. 8:57964. PubMed
  116. Kajiwara C, et al. 2018. J Immunol. 200:623. PubMed
  117. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  118. Ford J, et al. 2019. Front Immunol. 2.502083333. PubMed
  119. Li B, et al. 2019. Oncogenesis. 8:17. PubMed
  120. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  121. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  122. Haruwaka K, et al. 2019. Nat Commun. 4.455555556. PubMed
RRID
AB_312794 (BioLegend Cat. No. 101211)
AB_312795 (BioLegend Cat. No. 101212)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Forgot your password? Reset password?
Create an Account